Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This manuscript describes two radiotracer administration protocols for FDG-PET (constant infusion and bolus plus infusion) and compares them to bolus administration. Temporal resolutions of 16 s are achievable using these protocols.

Abstract

Functional positron emission tomography (fPET) provides a method to track molecular targets in the human brain. With a radioactively-labelled glucose analogue, 18F-fluordeoxyglucose (FDG-fPET), it is now possible to measure the dynamics of glucose metabolism with temporal resolutions approaching those of functional magnetic resonance imaging (fMRI). This direct measure of glucose uptake has enormous potential for understanding normal and abnormal brain function and probing the effects of metabolic and neurodegenerative diseases. Further, new advances in hybrid MR-PET hardware make it possible to capture fluctuations in glucose and blood oxygenation simultaneously using fMRI and FDG-fPET.

The temporal resolution and signal-to-noise of the FDG-fPET images is critically dependent upon the administration of the radiotracer. This work presents two alternative continuous infusion protocols and compares them to a traditional bolus approach. It presents a method for acquiring blood samples, time-locking PET, MRI, experimental stimulus, and administering the non-traditional tracer delivery. Using a visual stimulus, the protocol results show cortical maps of the glucose-response to external stimuli on an individual level with a temporal resolution of 16 s.

Introduction

Positron emission tomography (PET) is a powerful molecular imaging technique that is widely used in both clinical and research settings (see Heurling et al.1 for a recent comprehensive review). The molecular targets that can be imaged using PET are only limited by the availability of radiotracers, and numerous tracers have been developed to image neural metabolism receptors, proteins, and enzymes2,3. In neuroscience, one of the most used radiotracers is 18F-fluorodeoxyglucose (FDG-PET), which measures glucose uptake, usually interpreted as an index of cerebral glucose metabol....

Protocol

This protocol has been reviewed and approved by the Monash University Human Research Ethics Committee (approval number CF16/1108 - 2016000590) in accordance with the Australian National Statement on Ethical Conduct in Human Research24. Procedures were developed under the guidance of an accredited Medical Physicist, Nuclear Medicine Technologist, and clinical radiographer. Researchers should refer to their local experts and guidelines for the administration of ionizing radiation in humans.

Representative Results

Study-specific methods
Here, study-specific details for the representative results are reported. These details are not critical to the procedure and will vary across studies.

Participants and task design
Participants (n = 3, Table 2) underwent a simultaneous BOLD-fMRI/FDG-fPET study. As this manuscript focuses on the PET acquisition protocol, MRI re.......

Discussion

FDG-PET is a powerful imaging technology that measures glucose uptake, an index of cerebral glucose metabolism. To date, most neuroscience studies using FDG-PET use a traditional bolus administration approach, with a static image resolution that represents the integral of all metabolic activity over the course of the scan2. This manuscript describes two alternative radiotracer administration protocols: the infusion-only (e.g., Villien et al., Jamadar et al.19,

Acknowledgements

Jamadar is supported by an Australian Council for Research (ARC) Discovery Early Career Researcher Award (DECRA DE150100406). Jamadar, Ward, and Egan are supported by the ARC Centre of Excellence for Integrative Brain Function (CE114100007). Chen and Li are supported by funding from the Reignwood Cultural Foundation.

Jamadar, Ward, Carey, and McIntyre designed the protocol. Carey, McIntyre, Sasan, and Fallon collected the data. Jamadar, Ward, Parkes, and Sasan analyzed the data. Jamadar, Ward, Carey, and McIntyre wrote the first draft of the manuscript. All authors have reviewed and approved the final version.

....

Materials

NameCompanyCatalog NumberComments
Blood Collection Equipment
--12-15 vacutainersBecton Dickinson, NJ USA364880Remain in sterile packaging until required to put blood in tube
--12-15 10mL LH blood collecting tubesBecton Dickinson367526Marked with the sample number (e.g., S1, S2…) and subsequently marked with the sample time (e.g., time 0 + x min [T0+x])
--2-15 10mL Terumo syringeTerumo Tokyo, JapanSS+10LThese are drawn up on the day of the study and capped with the ampoule that contained the saline
-- pre-drawn 0.9% saline flushesPfizer, NY, USA61039117
--12-15 5mL Terumo syringesTerumo Tokyo, JapanSS+05SRemain in sterile packaging until ready to withdraw a blood sample
Safety & Waste EquipmentAll objects arranged on a plastic chair inside the scanner room on the same side as the arm from which the blood samples will be taken. Biohazard and non-biohazard waste bags to be used. Gloves and waste bags to be easily accessible when preparing the radioactivity in the dispensing area and when pipetting the plasma samples. Biohazard and non-biohazard waste bags to be used. All waste generated is checked with the Geiger counter to ensure that radioactive contaminated waste is stored until it is safe to be disposed of according to Australian Radiation Protection and Nuclear Safety Agency (APRANSA) guidelines for Radiation protection series No.6 (2017).
-- GlovesWestlab, VIC, Australia663-219
-- waste bagsAustar Packaging, VIC, AustraliaYIW6090
--cello underpads ‘blueys’ Underpads 5 PlyHalyard Health, NSW, Australia2765A
--Blue Sharpie penSharpie, TN, USAS30063
Dose SyringesRemain in sterile packaging until ready for use. All syringes used in this facility have an additional 20% volume capacity above the stated volume on the packaging. This is important for the 50mL syringe where the total capacity of 60mL is used
--5mLTerumo Tokyo, JapanSS+05S
-- 20mLTerumo Tokyo, JapanSS+20L
--50mLTerumo Tokyo, JapanSS*50LE
--1 Terumo 18-gauge needleTerumo Tokyo, JapanNN+1838RRemain in sterile packaging until ready to inject [18F]FDG into the saline bag
--100mL 0.9% saline bagBaxter Pharmaceutical, IL, USAAHB1307Remain in sterile packaging until ready to inject [18F]FDG
Radiochemistry Lab Supplies
--Heraeus Megafuge 16 centrifuge; Rotor Bioshield 720ThermoScientific MA, USA75004230Relative Centrifugal Force = 724 Our settings are 2000RPM for 5mins. Acceleration and deceleration curves set to 8
--Single well counterLaboratory Technologies, Inc. IL, USA630-365-1000Complete daily quality control (includes background count) and protocol set to 18F and 4mins. Cross calibration is performed between the well counter, dose calibrator and scanner on a bi-monthly basis.
--PipetteISG Xacto, Vienna, AustriaLI10434We use a 100-1000 μL set to 1000μL. It is calibrated annually.
--12-15 plasma counting tubesTechno PLAS; SA AustraliaP10316SUMarked in the same manner as the LH blood tubes
--12-15 pipette tipsExpell Capp, Denmark5130140-1
--3 test tube racksGenericChecked with a Geiger counter to ensure there is no radiation contamination on them
--500mL volumetric flask and distilled waterGenericNeed approximately 500mL of distilled water to prepare the reference for gamma counting
--Synchronised clocks in scanner room, console and radiochemistry labGenericSynchronisation checks are routinely completed in the facility on a weekly basis
--Haemoglobin MonitorEKF Diagnostic Cardiff, UK Haemo Control.3000-0810-6801Manufacturer recommended quality control performed before testing on participant’s blood sample.
--GlucometreRoche Accu-Chek6870252001Accu-Chek Performa is used to measure participant blood sugar levels in mmol/L. Quality control is performed daily using high and low concentration solution control test.
Cannulating EquipmentCheck expiry dates and train NMT to prepare aseptically for cannulation.
--Regulation tourniquetCBC Classic Kimetec GmBHK5020
--20, 22 and 24 gauge cannulasBraun, Melsungen Germany4251644-03; 4251628-03; 4251601-03
--tegaderm dressings3M, MN USA1624W
--alcohol and chlorhexidine swabsReynard Health Supplies, NSW AustraliaRHS408
--0.9% saline 10mL ampoules; for flushesPfizer, NY, USA61039117
--10mL syringesTerumo Tokyo, JapanSS+10L
--3-way tapBecton Dickinson Connecta394600
--IV bungSafsite Braun PA USA415068
--Optional extension tube, microbore extension setM Devices, DenmarkIV054000
Scanner Room Equipment
--Siemens Biograph 3T mMRSiemens, Erlangen, Germany
--Portable lead barrier shieldGammasonicsCustom-builtMR-conditional lead barrier shield. Positioned at the 2000 Gauss line with the castors locked to provide additional shielding of the radioactivity connected to the infusion pump.
--Infusion pump BodyGuard 323 MR-conditional infusion pumpCaesarea Medical Electronics300-040XPMR-compatible. This model is cleared for use on 1.5 and 3T scanners at 2000 Gauss with castors locked.
--Infusion pump tubingCaesarea Medical Electronics100-163X2YNKSTubing is administration set with an anti-siphon valve and male luer lock (REF 100-163X2YNKS).
--Lead bricksCustom builtTested for ferromagnetic translational force
Other Equipment
--Syringe shieldsBiodex, NY USACustom-builtThere is a 5mL tungsten syringe shield that is MR-safe, as well as a 50mL lead shield that has been tested for ferromagnetic attraction prior to use in the MR-PET scanner. It is used to transport the radioactive dose from the radiochemistry lab into the scanner to minimise radiation exposure to the NMT.
--Geiger counter Model 26-1 Integrated FriskerLudlum Measurements, Inc. TX USA48-4007This is calibrated annually and used to monitor potential contamination and waste. It is not taken into the MR-PET scanner.

References

Explore More Articles

AI WriterPETFDG PETMR PETRadiochemistryInfusionBolusTemporal ResolutionGlucoseBrain Imaging

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved